March 5, 2009 9:11 AM
- Text
New Weapon For Stroke Victims
(AP)
Scientists working with mice have found that a compound used to fight severe blood infections may be useful in preventing stroke damage.
Activated protein C was found to reduce the likelihood that brain cells would self-destruct after a stroke, the researchers report in Monday's online issue of the journal Nature Medicine.
Strokes occur when the blood supply is cut off to part of the brain, by a blood clot for example. Some cells die right away; others are damaged and self-destruct later in a process called apoptosis.
In mice that had strokes, some 65 percent of the cells that would have died after the stroke survived when the mice was treated with the protein, according to the lead researcher, Dr. Berislav Zlokovic of the University of Rochester in Rochester, N.Y.
The protein also is the active ingredient in a drug approved two years ago for human use in the treatment of sepsis, a severe blood infection that can be deadly. In that case it acts by reducing blood clotting and inflammation.
In the case of a stroke victim, the protein decreases the cellular signals that persuade brain cells to kill themselves after a stroke and boosts signals that persuade the cells to survive, according to Zlokovic and co-lead author John H. Griffin of Scripps Research Institute in La Jolla, Calif.
Some of the research was done in collaboration with Socratech Laboratories, a Rochester company founded by Zlokovic.
Activated protein C was found to reduce the likelihood that brain cells would self-destruct after a stroke, the researchers report in Monday's online issue of the journal Nature Medicine.
Strokes occur when the blood supply is cut off to part of the brain, by a blood clot for example. Some cells die right away; others are damaged and self-destruct later in a process called apoptosis.
In mice that had strokes, some 65 percent of the cells that would have died after the stroke survived when the mice was treated with the protein, according to the lead researcher, Dr. Berislav Zlokovic of the University of Rochester in Rochester, N.Y.
The protein also is the active ingredient in a drug approved two years ago for human use in the treatment of sepsis, a severe blood infection that can be deadly. In that case it acts by reducing blood clotting and inflammation.
In the case of a stroke victim, the protein decreases the cellular signals that persuade brain cells to kill themselves after a stroke and boosts signals that persuade the cells to survive, according to Zlokovic and co-lead author John H. Griffin of Scripps Research Institute in La Jolla, Calif.
Some of the research was done in collaboration with Socratech Laboratories, a Rochester company founded by Zlokovic.
Popular Now in Health
- Cancer drug reverses Alzheimer's in mice: Study
- Norovirus outbreak hits Rider University in N.J
- Marijuana-smoking motorists twice as likely to crash
- Electric shocks to brain may boost memory: Study
- Chinese mom gives birth to 15-pound baby
- America's sodium problem: Not from salty snacks?
- America's pets also have an obesity epidemic
- Caffeine inhalers - the next club drug?
- Measles patient at Super Bowl prompts health alert
- Skin cancer self-exam: What to look for (PHOTOS)
- 4.5 million Americans over 50 have artificial knees
- Things You Didn't Know About Your Penis
- PICTURES: 15 Shocking Sexual Fetishes
- Drinking soda raises risk for asthma, COPD: Study
- Let's Move! campaign turns 2 today: Is it working?
- Woman spotlights uterus didelphys on talk show
- Dr. Liar? Study finds dishonest docs common
Latest CBS News Headlines
on Facebook
on CBS News
- Social worker recounts minutes before Powell fire
- Embalmer takes speech case to Mass. high court
- Embalmer takes speech case to Mass. high court
- British man wanted in '93 heist arrested in Mo.
on Facebook
- Adele sings a cappella for Anderson Cooper
- Josh Powell had "incestuous" images on his home computer, authorities say
on CBS News






